The Week Ahead: Google, Amazon, and Pfizer to Report Earnings
Other big names in the energy and healthcare sectors are on the calendar for the week ahead as well.
Other big names in the energy and healthcare sectors are on the calendar for the week ahead as well.
On Tuesday, we are looking out for reports from Alphabet (GOOGL), Amazon.com (AMZN), and Pfizer (PFE).
Following the Jan. 6 riot at the U.S. Capitol, we do not think there will be a significant impact on Google. The media giant's decision to remove Parler from the Google Play app store appears to align with its policies. This creates slight risk for Google's cloud business as decentralization may become a topic of cloud conversations after Amazon decided to no longer host the Parler app on its cloud, leading to the app's end.
Amazon continues to find ways to evolve in almost every industry. The wide-moat online retailer continues to outpace global e-commerce trends, and although more retailers are expanding online, we think Amazon will still reign as the leader in this space thanks to Prime shipping, an expanding digital content library, and new customer services.
After more than 83 million reported cases and 1.8 million reported deaths globally because of coronavirus this past year, Pfizer's vaccine with BioNTech (BNTX) has set a high bar for efficacy and safety, and we expect it to dominate the U.S. market throughout the first half of 2021. We anticipate $39 billion in COVID-19 vaccine sales this year, with Pfizer/BioNTech accounting for nearly $14 billion in sales.
On Wednesday, we expect to see reports from AbbVie (ABBV) and Enterprise Products Partners (EPD). Reports from Gilead Sciences (GILD), Ford Motor (F), and Merck (MRK) are on our list for Thursday.
Carole Hodorowicz does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.